Literature DB >> 2303779

Growth autonomy and tumorigenicity of interleukin 6-dependent B cells transfected with interleukin 6 cDNA.

N Tohyama1, H Karasuyama, T Tada.   

Abstract

We introduced an IL-6 cDNA expression vector into a murine B cell line, the growth of which definitely required the presence of exogenous IL-6. The transfected cells secreted substantial amounts of IL-6, to which they themselves responded by proliferating without further requirement of exogenous IL-6. The proliferation was a direct function of cell density and was inhibitable by antibodies to IL-6, indicating the autocrine nature of the growth. The IL-6 cDNA-transfected cells displayed greatly enhanced tumorigenicity when inoculated into syngeneic and nude mice. Our data suggest that an IL-6 autocrine self stimulation confers on B cells a selective growth advantage and results in the induction of progression of the malignant state of B cells.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2303779      PMCID: PMC2187732          DOI: 10.1084/jem.171.2.389

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  38 in total

1.  A new mouse myeloma cell line that has lost immunoglobulin expression but permits the construction of antibody-secreting hybrid cell lines.

Authors:  J F Kearney; A Radbruch; B Liesegang; K Rajewsky
Journal:  J Immunol       Date:  1979-10       Impact factor: 5.422

2.  Multiple actions of interleukin 6 within a cytokine network.

Authors:  G G Wong; S C Clark
Journal:  Immunol Today       Date:  1988-05

3.  Growth factors from murine sarcoma virus-transformed cells.

Authors:  J E de Larco; G J Todaro
Journal:  Proc Natl Acad Sci U S A       Date:  1978-08       Impact factor: 11.205

Review 4.  Molecular regulation of B lymphocyte response.

Authors:  T Kishimoto; T Hirano
Journal:  Annu Rev Immunol       Date:  1988       Impact factor: 28.527

5.  Direct transfer of cloned genes from bacteria to mammalian cells.

Authors:  W Schaffner
Journal:  Proc Natl Acad Sci U S A       Date:  1980-04       Impact factor: 11.205

6.  Purification and NH2-terminal sequence of a plasmacytoma growth factor derived from the murine macrophage cell line P388D1.

Authors:  R P Nordan; J G Pumphrey; S Rudikoff
Journal:  J Immunol       Date:  1987-08-01       Impact factor: 5.422

7.  Identification of a common nucleotide sequence in the 3'-untranslated region of mRNA molecules specifying inflammatory mediators.

Authors:  D Caput; B Beutler; K Hartog; R Thayer; S Brown-Shimer; A Cerami
Journal:  Proc Natl Acad Sci U S A       Date:  1986-03       Impact factor: 11.205

8.  B cell stimulatory factor-2 is involved in the differentiation of cytotoxic T lymphocytes.

Authors:  Y Takai; G G Wong; S C Clark; S J Burakoff; S H Herrmann
Journal:  J Immunol       Date:  1988-01-15       Impact factor: 5.422

9.  Human cutaneous T cell lymphoma and leukemia cell lines produce and respond to T cell growth factor.

Authors:  J E Gootenberg; F W Ruscetti; J W Mier; A Gazdar; R C Gallo
Journal:  J Exp Med       Date:  1981-11-01       Impact factor: 14.307

10.  Interleukin-HP1, a T cell-derived hybridoma growth factor that supports the in vitro growth of murine plasmacytomas.

Authors:  J Van Snick; A Vink; S Cayphas; C Uyttenhove
Journal:  J Exp Med       Date:  1987-03-01       Impact factor: 14.307

View more
  12 in total

1.  Interleukin-6 is antiproliferative to a mouse hybridoma cell line and promotive for its antibody productivity.

Authors:  F Makishima; S Terada; T Mikami; E Suzuki
Journal:  Cytotechnology       Date:  1992       Impact factor: 2.058

2.  Characterization and fed-batch culture of hybridoma overexpressing apoptosis suppressing gene bcl-2.

Authors:  S Terada; Y Itoh; H Ueda; E Suzuki
Journal:  Cytotechnology       Date:  1997-07       Impact factor: 2.058

3.  Establishing apoptosis resistant cell lines for improving protein productivity of cell culture.

Authors:  E Suzuki; S Terada; H Ueda; T Fujita; T Komatsu; S Takayama; J C Reed
Journal:  Cytotechnology       Date:  1997-01       Impact factor: 2.058

4.  Detection of inflammatory cytokines in psoriatic skin.

Authors:  Y Yoshinaga; M Higaki; S Terajima; E Ohkubo; T Nogita; N Miyasaka; M Kawashima
Journal:  Arch Dermatol Res       Date:  1995       Impact factor: 3.017

5.  Reduced inflammation in the tumor microenvironment delays the accumulation of myeloid-derived suppressor cells and limits tumor progression.

Authors:  Stephanie K Bunt; Linglin Yang; Pratima Sinha; Virginia K Clements; Jeff Leips; Suzanne Ostrand-Rosenberg
Journal:  Cancer Res       Date:  2007-10-15       Impact factor: 12.701

Review 6.  Interleukin-6, a new target for therapy in multiple myeloma?

Authors:  M H van Oers; H C van Zaanen; H M Lokhorst
Journal:  Ann Hematol       Date:  1993-05       Impact factor: 3.673

7.  Interleukin-7 retroviruses transform pre-B cells by an autocrine mechanism not evident in Abelson murine.

Authors:  R W Overell; L Clark; D Lynch; R Jerzy; A Schmierer; K E Weisser; A E Namen; R G Goodwin
Journal:  Mol Cell Biol       Date:  1991-03       Impact factor: 4.272

8.  Establishment of an apoptosis-suppressible,cell-cycle arrestable cell line and its applicationfor enhancing protein production of serum-free or-supplemented culture.

Authors:  Y H Kim; A Kitayama; M Takahashi; E Niki; E Suzuki
Journal:  Cytotechnology       Date:  2000-02       Impact factor: 2.058

9.  Mouse plasmacytoma growth in vivo: enhancement by interleukin 6 (IL-6) and inhibition by antibodies directed against IL-6 or its receptor.

Authors:  A Vink; P Coulie; G Warnier; J C Renauld; M Stevens; D Donckers; J Van Snick
Journal:  J Exp Med       Date:  1990-09-01       Impact factor: 14.307

10.  A complex of glycoproteins is associated with VpreB/lambda 5 surrogate light chain on the surface of mu heavy chain-negative early precursor B cell lines.

Authors:  H Karasuyama; A Rolink; F Melchers
Journal:  J Exp Med       Date:  1993-08-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.